Do You Still Have A Reason To Buy OptimizeRx Corp (NASDAQ: OPRX) After A 8.58% Jump In The Last Week?

IPW

During the last session, OptimizeRx Corp (NASDAQ:OPRX)’s traded shares were 0.49 million, with the beta value of the company hitting 1.08. At the end of the trading day, the stock’s price was $10.12, reflecting an intraday gain of 15.00% or $1.32. The 52-week high for the OPRX share is $16.65, that puts it down -64.53 from that peak though still a striking 31.62% gain since the share price plummeted to a 52-week low of $6.92. The company’s market capitalization is $183.98M, and the average trade volume was 122.81K shares over the past three months.

OptimizeRx Corp (NASDAQ:OPRX) trade information

OptimizeRx Corp (OPRX) registered a 15.00% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 15.00% in intraday trading to $10.12, hitting a weekly high. The stock’s 5-day price performance is 8.58%, and it has moved by -16.71% in 30 days. Based on these gigs, the overall price performance for the year is -31.53%.

OptimizeRx Corp (OPRX) estimates and forecasts

Statistics show that OptimizeRx Corp has outperformed its competitors in share price, compared to the industry in which it operates. OptimizeRx Corp (OPRX) shares have gone up 27.46% during the last six months, with a year-to-date growth rate more than the industry average at 19.23% against 15.20. In the rating firms’ projections, revenue will increase 44.30% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 17.03M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 21.2M by the end of current fiscal year.

While earnings are projected to return 44.62% in 2024, the next five years will return 11.50% per annum.

OPRX Dividends

OptimizeRx Corp is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

OptimizeRx Corp (NASDAQ:OPRX)’s Major holders